Treatment-free survival according to randomization. Sixty-four (37.6%) of 170 patients treated with fludarabine and 41 (23.4%) of 175 patients treated with FC received second-line treatment or died. Median treatment-free survival time was 25 months compared with 37 months (P < .001).